Tiziana Life Sciences Files For Small IPO [Seeking Alpha]
CONATUS PHARMACEUTICALS INC (CNAT)
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.conatuspharma.com/investor-relations
Company Research
Source: Seeking Alpha
Summary Tiziana Life Sciences aims to raise $11.5 million in a U.S. IPO. The UK-based firm is advancing a pipeline of drug treatment candidates for cancer and immune diseases. TLSA has made regulatory progress with its pipeline but faces the most expensive stages of clinical trials over the next few years. Quick Take Tiziana Life Sciences ( TLSA ) intends to raise gross proceeds of $11.5 million from a U.S. IPO, according to an F-1 registration statement . The firm is developing therapeutics and diagnosis for cancers and immune diseases. TLSA is preparing for Phase 3 trials for its lead candidates to begin in 2019, but investors will likely need to wait until at least 2020 before hearing topline results from those trials. I'll provide a final opinion when we learn more IPO details from management. Company & Technology The Mayfair, UK-based biotechnology company was founded in 2013 to develop new molecules to treat oncology and immunology
Show less
Read more
Impact Snapshot
Event Time:
CNAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNAT alerts
High impacting CONATUS PHARMACEUTICALS INC news events
Weekly update
A roundup of the hottest topics